Paldeep Atwal
Clinical Genetics (M.D.) · West Palm Beach, FLNPI 1518201243
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $77,551 of the $120,982 with a category attached, or 64.1%. 8 manufacturers reported payments, led by Sanofi at 46.2% of the total. Reporting peaked in 2019 at $55,302 and has fallen 99.8% since, to $117 in 2025. Among clinical genetics (m.d.) clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $840.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$56K
- Amgen$33K
- PTC Therapeutics, Inc.$23K
- Ipsen Biopharmaceuticals, Inc$9K
- Biomarin Pharmaceutical Inc.$265
- Sanofi-aventis U.S. LLC$137
- plus $77 from 2 others
Across 2 payments — averaging $765.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$2K
What the payments were for
- Consulting fees$16,55014%
- Speaking & faculty fees$77,55164%
- Travel & lodging$23,51919%
- Food & beverage$3,3623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 54 | $55,879 |
| Amgen | 47 | $33,374 |
| PTC Therapeutics, Inc. | 24 | $22,583 |
| Ipsen Biopharmaceuticals, Inc | 9 | $8,666 |
| Biomarin Pharmaceutical Inc. | 5 | $265 |
| Sanofi-aventis U.S. LLC | 3 | $137 |
| Sentynl Therapeutics, Inc. | 1 | $45 |
| Amicus Therapeutics, Inc. | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FABRAZYME$21,957
- RAVICTI$21,945
- CERDELGA$12,044
- CEREZYME$12,044
- LUMIZYME$11,172
- PROCYSBI$10,473
- DISEASE STATE$2,760
- ALDURAZYME$2,100
- Sohonos$1,971
- Palynziq$117
- NEXVIAZYME$109
How this compares
$120,982 in reported general payments places this provider in the 90th percentile of 37 clinical genetics (m.d.) providers in Florida.
Other clinical genetics (m.d.) in West Palm Beach
- Roberto ZoriGainesville$169K
- Amarilis Sanchez ValleTampa$166K
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Ingrid CristianOrlando$38K
- Maria DescartesFort Myers$9K
- Klaas WierengaGainesville$5K
- Irman ForghaniMiami$3K
- Sajel LalaMiami$2K
- Ana Marie Rodriguez BarretoMiami$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.